AC Immune SA - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 8731 https://www.acimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings? - Feb 20th, 2019 6:54 am
What's in Store for Tandem Diabetes' (TNDM) Q4 Earnings? - Feb 20th, 2019 5:35 am
AC Immune Announces Anti-Tau Monoclonal Antibody Entering Second Phase 2 Trial in Moderate Alzheimer’s Disease - Feb 20th, 2019 5:00 am
AC Immune Makes Two Appointments to Executive Committee to Accelerate Product Development - Feb 7th, 2019 5:00 am
What Makes AC Immune (ACIU) a New Buy Stock - Feb 6th, 2019 7:10 am
AC Immune Enters Oversold Territory - Feb 1st, 2019 6:37 am
Why AC Immune SA Stock Crashed on January 30 - Jan 31st, 2019 6:15 am
Roche Halts Two Late-Stage Studies on Alzheimer's Candidate - Jan 30th, 2019 2:47 pm
Roche Scraps Alzheimer's Test — But Investors Punished This Stock - Jan 30th, 2019 2:42 pm
Roche, AC Immune drop Alzheimer drug trials after setback - Jan 30th, 2019 9:41 am
Why AC Immune SA Is Imploding - Jan 30th, 2019 8:16 am
Genentech kills big drug study in early Alzheimer's patients - Jan 30th, 2019 7:49 am
Roche drops Alzheimer drug trials after setback - Jan 29th, 2019 11:36 pm
AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease - Jan 29th, 2019 11:00 pm
Top Ranked Momentum Stocks to Buy for January 25th - Jan 25th, 2019 8:30 am
Moving Average Crossover Alert: AC Immune - Jan 17th, 2019 4:56 am
Stemline Therapeutics (STML) in Focus: Stock Moves 9.5% Higher - Jan 16th, 2019 7:01 am
Biogen Inks Two Deals to Make Drugs for Neurological Diseases - Jan 7th, 2019 1:51 pm
AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer - Jan 3rd, 2019 2:00 am
WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership - Dec 19th, 2018 5:16 am